Lynn Bichajian

Lynn Bichajian serves as the Senior Medical Director in Clinical Drug Development at Eagle Pharmaceuticals, Inc. since June 2022, prior to which the position of Medical Science Liaison was held at Acacia Pharma Inc. from November 2018 to June 2022, and the role of Senior Medical Science Liaison in the Medical Affairs department at Mallinckrodt Pharmaceuticals from February 2016 to November 2018. Lynn has a robust background in anesthesiology, having worked as an anesthesiologist for Anesthesia Associates of Massachusetts from September 2001 to March 2015 and Anesthesiologists of Mount Auburn from September 1994 to September 2001. Educational qualifications include a Doctor of Medicine from the University of Miami Miller School of Medicine, a Bachelor of Arts in Psychology from Cornell University, and extensive training in anesthesia at Brigham and Women's Hospital, Harvard Medical School, including roles as Chief Resident and Resident.